NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics today reported that its second quarter revenues increased 20 percent year over year on higher product revenues.

The firm reported revenues of €487,000 ($532,096) versus revenues of €405,000 for the second quarter of 2015. The company said that its product revenues increased 36 percent to €289,000 versus €212,000 in the prior-year period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.